Title : A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation.

Pub. Date : 2017 Oct

PMID : 28846937






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. BTYNB MYC proto-oncogene, bHLH transcription factor Homo sapiens
2 The small molecule, BTYNB, was identified as a potent and selective inhibitor of IMP1 binding to c-Myc mRNA. BTYNB MYC proto-oncogene, bHLH transcription factor Homo sapiens
3 BTYNB destabilizes c-Myc mRNA, resulting in downregulation of c-Myc mRNA and protein. BTYNB MYC proto-oncogene, bHLH transcription factor Homo sapiens
4 BTYNB destabilizes c-Myc mRNA, resulting in downregulation of c-Myc mRNA and protein. BTYNB MYC proto-oncogene, bHLH transcription factor Homo sapiens
5 With its ability to target c-Myc and to inhibit proliferation of difficult-to-target melanomas and ovarian cancer cells, and with its unique mode of action, BTYNB is a promising small molecule for further therapeutic evaluation and mechanistic studies. BTYNB MYC proto-oncogene, bHLH transcription factor Homo sapiens